We may have a new champion when it comes to pills that can manage both blood sugar levels and weight loss. In a phase 3 ...

(Competitive Insight/Unsplash) While GLP-1 drugs such as Wegovy and Ozempic are now being broadly championed and widely used, ...

Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely ...

Downside to dropping pounds? The new pill form of popular GLP-1 drugs contains a compound that could cause troubling side ...

Eye strokes’ that reduce blood flow to optic nerve likely to be side-effect of active ingredient semaglutide, says author ...

Ozempic and Wegovy users who have suffered blindness, vomiting and even the loss of a loved one have warned about the 'dark ...

This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Semaglutide nausea is common: About 20 percent of Ozempic® ...

Ischaemic optic neuropathy (ION) is a rare but vision-threatening complication recently linked to GLP-1 receptor agonists, particularly semaglutide. Using over 30 million reports from the FDA Adverse ...

Researchers found that the odds of developing an eye condition that leads to vision loss were about 5 times higher among those on Wegovy than among those on Ozempic.

As geopolitical uncertainties persist, the possibility of a Canadian-made version of one of the most popular drugs in the ...

Ozempic started the weight-loss drug frenzy, and it continues to be a famous name in the fight against obesity, even though it's not approved for that purpose. The blockbuster medication is meant to ...

The generic versions of semaglutide are expected to be at least 50% cheaper— ₹5,000 for a weekly dose—than Ozempic in India .